Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older

Objectives A multicentre prospective non‐randomised study of de novo acute myeloid leukaemia (AML) in patients aged ≥70 yr was designed to reduce toxicity and achieve acceptable complete remission (CR) rates. Methods The outpatient treatment included induction with oral fludarabine, subcutaneous cyt...

Ausführliche Beschreibung